We provide access to a broad spectrum of institutional basic and technology-rich core lab facilities and resources at UNC and partner institutions including NC State University, N.C. A&T State University, and RTI International.
We provide access to a broad spectrum of institutional basic and technology-rich core lab facilities at UNC and partner institutions.
UNC's core facilities are shared resources which offer a wide range of services to the research community, including cutting edge technologies, high end instrumentation, technical support and education. Our facilities enhance and expand the collaborative capabilities of research at UNC-Chapel Hill. We provide operational support to biomedical research core facilities.
Researchers at NC State, N.C. A&T, RTI, and other institutions and industry can access, and are welcome to use, all of the UNC-Chapel Hill core lab facilities and resources. N.C. A&T and RTI users have the same priority for core services and resources as all internal UNC-Chapel Hill researchers on a first-come, first-serve basis.
NC State offers access to its Biomedical Clinical Manufacturing Facility. Focusing on stem cells and regenerative medicine, the facility supports Phase I human clinical trials and is particularly helpful to faculty and small startups.
This facility was developed to produce novel products under controls consistent with US FDA current Good Manufacturing Practices (cGMP).
Work in the facility focuses on isolation and expansion of human cells. Under cGMP controls, manipulated cells will be of appropriate quality for use in Phase I, first in human, clinical trials in accordance with the IND protocol controlling the work.
Open to researchers collaborating with any N.C. A&T faculty, a Zeiss Center for Microscopy (electron microscopy) is located at the Gateway University Research Park. Access is alternatively available via purchase of a membership to Gateway's Nanomanufacturing Innovation Consortium. The minimum membership fee of $5,000 is applied against subsequent instrument use charges.
N.C. A&T is currently working with TraCS to set up its first core facility, which will include an X-ray nanoCT™ system, a GE Phoenix nanotom-M 1880. While this core is under construction, the instruments are available via collaborative research projects.
The EPDD service can assist researchers by providing target development and assay miniaturization, identification of hits through HTS in a 70,000-compound library, lead optimization, in vitro ADMET assays, and preliminary in vivo PK studies.
Learn more about Drug Discovery and Development at RTI.
To learn more about all services and resources available through RTI, and how to engage with RTI services, contact Lisa Gehtland.